FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100352795> ?p ?o ?g. }

• W3100352795 abstract "Objective: Assess efficacy and safety of incobotulinumtoxinA in lower-limb (LL) or combined LL/upper-limb (LL/UL) spasticity in children and adolescents with cerebral palsy (CP). Background: Spasticity is the most prominent movement disorder in children with CP. Design/Methods: Two phase III studies; a lead-in prospective, double-blind, randomized study (TIM) followed by an open-label, non-controlled study (TIMO). TIM had three parallel dose groups (4 U/kg body weight (BW), 12 U/kg BW, 16 U/kg BW); subjects were randomized in a 1:1:2 ratio and received 2 double-blind injection cycles. In TIMO, subjects who had completed TIM, or newly recruited treatment-naive or pre-treated subjects, received 4 injection cycles with the highest dose of TIM. The primary endpoints of TIM were change from baseline in Ashworth Scale (AS) of the plantar flexors (PF) score at Week 4 of Cycle 1, and the Investigator’s Global Impression of Change of Plantar Flexor Spasticity Scale (GICS-PF) score at Week 4 of Cycle 1. TIMO was focused on safety, and did not have primary efficacy endpoints. Results: In TIM, all 3 dose groups experienced a statistically significant improvement in AS-PF score 4 weeks post-injection versus baseline. In TIMO, cumulative improvements in AS scores for the PF, knee flexors and thigh adductors were observed from TIM baseline to 4 weeks post-injection. Investigator’s GICS-PF scores indicated a positive response to treatment in all dose groups 4 weeks post-injection in TIM Cycle 1 and improvements were maintained in all treatment groups in Cycle 2. Respective clinical assessments also confirmed consistent improvement in LL and UL spasticity at Week 4 in all TIMO injection cycles. Both studies had good overall safety profiles. Conclusions: IncobotulinumtoxinA at total doses up to 16–20 U/kg is effective and well tolerated for the multi-level, multi-pattern treatment of LL/UL spasticity due to CP in children and adolescents. Disclosure: Dr. Dabrowski has nothing to disclose. Dr. Chambers has nothing to disclose. Dr. Heinen has nothing to disclose. Dr. Kanovsky has nothing to disclose. Dr. Schroeder has nothing to disclose. Dr. Graham has nothing to disclose. Dr. Banach has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz. Dr. Banach has received research support from Merz, Ipsen, Kedrion, Shire, Allergan. Dr. Dersch has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz Pharmaceuticals GmBH. Dr. Geister has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz Pharmaceuticals GmBH. Dr. Martinez-Torres has nothing to disclose. Dr. Pulte has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz Pharmaceuticals GmBH. Dr. Gaebler-Spira has nothing to disclose." @default.
• W3100352795 created "2020-11-23" @default.
• W3100352795 creator A5004615352 @default.
• W3100352795 creator A5006886471 @default.
• W3100352795 creator A5018640268 @default.
• W3100352795 creator A5024093171 @default.
• W3100352795 creator A5039317992 @default.
• W3100352795 creator A5047243893 @default.
• W3100352795 creator A5050899654 @default.
• W3100352795 creator A5059889856 @default.
• W3100352795 creator A5065162668 @default.
• W3100352795 creator A5082822382 @default.
• W3100352795 creator A5087399449 @default.
• W3100352795 creator A5088879381 @default.
• W3100352795 date "2020-04-14" @default.
• W3100352795 modified "2023-09-29" @default.
• W3100352795 title "Multi-level and Multi-pattern Lower- and Upper-limb Spasticity Treatment with IncobotulinumtoxinA in Children and Adolescents with Cerebral Palsy (1548)" @default.
• W3100352795 hasPublicationYear "2020" @default.
• W3100352795 type Work @default.
• W3100352795 sameAs 3100352795 @default.
• W3100352795 citedByCount "0" @default.
• W3100352795 crossrefType "journal-article" @default.
• W3100352795 hasAuthorship W3100352795A5004615352 @default.
• W3100352795 hasAuthorship W3100352795A5006886471 @default.
• W3100352795 hasAuthorship W3100352795A5018640268 @default.
• W3100352795 hasAuthorship W3100352795A5024093171 @default.
• W3100352795 hasAuthorship W3100352795A5039317992 @default.
• W3100352795 hasAuthorship W3100352795A5047243893 @default.
• W3100352795 hasAuthorship W3100352795A5050899654 @default.
• W3100352795 hasAuthorship W3100352795A5059889856 @default.
• W3100352795 hasAuthorship W3100352795A5065162668 @default.
• W3100352795 hasAuthorship W3100352795A5082822382 @default.
• W3100352795 hasAuthorship W3100352795A5087399449 @default.
• W3100352795 hasAuthorship W3100352795A5088879381 @default.
• W3100352795 hasConcept C141071460 @default.
• W3100352795 hasConcept C168563851 @default.
• W3100352795 hasConcept C1862650 @default.
• W3100352795 hasConcept C203092338 @default.
• W3100352795 hasConcept C2776660947 @default.
• W3100352795 hasConcept C2779012798 @default.
• W3100352795 hasConcept C2779421357 @default.
• W3100352795 hasConcept C2780566999 @default.
• W3100352795 hasConcept C42219234 @default.
• W3100352795 hasConcept C71924100 @default.
• W3100352795 hasConceptScore W3100352795C141071460 @default.
• W3100352795 hasConceptScore W3100352795C168563851 @default.
• W3100352795 hasConceptScore W3100352795C1862650 @default.
• W3100352795 hasConceptScore W3100352795C203092338 @default.
• W3100352795 hasConceptScore W3100352795C2776660947 @default.
• W3100352795 hasConceptScore W3100352795C2779012798 @default.
• W3100352795 hasConceptScore W3100352795C2779421357 @default.
• W3100352795 hasConceptScore W3100352795C2780566999 @default.
• W3100352795 hasConceptScore W3100352795C42219234 @default.
• W3100352795 hasConceptScore W3100352795C71924100 @default.
• W3100352795 hasOpenAccess W3100352795 @default.
• W3100352795 hasRelatedWork W1042487492 @default.
• W3100352795 hasRelatedWork W1481588157 @default.
• W3100352795 hasRelatedWork W1555860353 @default.
• W3100352795 hasRelatedWork W2047565140 @default.
• W3100352795 hasRelatedWork W2461310150 @default.
• W3100352795 hasRelatedWork W2562731026 @default.
• W3100352795 hasRelatedWork W2794555652 @default.
• W3100352795 hasRelatedWork W2805735816 @default.
• W3100352795 hasRelatedWork W2806417025 @default.
• W3100352795 hasRelatedWork W2808055426 @default.
• W3100352795 hasRelatedWork W2808114370 @default.
• W3100352795 hasRelatedWork W2809523820 @default.
• W3100352795 hasRelatedWork W2809684180 @default.
• W3100352795 hasRelatedWork W2883358571 @default.
• W3100352795 hasRelatedWork W2885430857 @default.
• W3100352795 hasRelatedWork W2886259731 @default.
• W3100352795 hasRelatedWork W2890443921 @default.
• W3100352795 hasRelatedWork W2898365980 @default.
• W3100352795 hasRelatedWork W2900129824 @default.
• W3100352795 hasRelatedWork W2976572331 @default.
• W3100352795 hasVolume "94" @default.
• W3100352795 isParatext "false" @default.
• W3100352795 isRetracted "false" @default.
• W3100352795 magId "3100352795" @default.
• W3100352795 workType "article" @default.